Volume 24, Issue 10
Highlights on Fluorine-containing Drugs Approved by U.S. FDA in 2023
Pp: 843-849
Author(s): Saghir Ali, Andrew A. Bolinger and Jia Zhou*
DOI: 10.2174/0115680266300245240223070242
The Unveiling of Therapeutic Targets for Alzheimer’s Disease: An Integrative Review
Pp: 850-868
Author(s): Pratiksha Madar*, Pooja Nagalapur, Somdatta Chaudhari, Devesh Sharma, Akshada Koparde, Rahul Buchade, Sandip Kshirsagar, Pravin Uttekar, Shailaja Jadhav and Praveen Chaudhari
DOI: 10.2174/0115680266282492240220101049
Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications
Pp: 869-884
Author(s): Lei Wu, Lin Bai, Wenshu Dai, Yaping Wu, Pengjun Xi, Jie Zhang and Lily Zheng*
DOI: 10.2174/0115680266283661240226052054
Synthetic Strategies of Thiazolidine-2,4-dione Derivatives for the Development of New Anti-diabetic Agents: Compressive Review
Pp: 885-928
Author(s): Pushkar Kumar Ray*, Km Shabana, Salahuddin and Rajnish Kumar
DOI: 10.2174/0115680266284283240304071648
